Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Bruker Corporation (BRKR)

62.3   -0.13 (-0.21%) 09-29 16:00
Open: 62.97 Pre. Close: 62.43
High: 63.41 Low: 62.07
Volume: 524,785 Market Cap: 9,149(M)

Technical analysis

as of: 2023-09-29 4:26:18 PM
Short-term rate:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Mid-term rate:       
Target: Six months: 76.93     One year: 80.56
Support: Support1: 60.83    Support2: 50.61
Resistance: Resistance1: 65.86    Resistance2: 68.98
Pivot: 63.49
Moving Average: MA(5): 62.24     MA(20): 63.49
MA(100): 69.65     MA(250): 69.76
MACD: MACD(12,26): -1     Signal(9): -0.9
Stochastic oscillator: %K(14,3): 18.4     %D(3): 15.7
RSI: RSI(14): 43.4
52-week: High: 84.83  Low: 52.22
Average Vol(K): 3-Month: 897 (K)  10-Days: 659 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ BRKR ] has closed above bottom band by 33.3%. Bollinger Bands are 4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 63.48 - 63.82 63.82 - 64.1
Low: 61.28 - 61.66 61.66 - 61.98
Close: 61.68 - 62.32 62.32 - 62.87

Company Description

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Headline News

Fri, 29 Sep 2023
New Mexico Educational Retirement Board Acquires 2300 Shares of ... - MarketBeat

Wed, 27 Sep 2023
Bruker Co. (NASDAQ:BRKR) Stock Position Raised by Pacer ... - MarketBeat

Thu, 21 Sep 2023
Congress Wealth Management LLC DE Purchases Shares of ... - MarketBeat

Tue, 19 Sep 2023
Bruker (BRKR) Advances Novel 4D-Proteomics Capabilities - Nasdaq

Mon, 18 Sep 2023
State Board of Administration of Florida Retirement System Sells ... - MarketBeat

Wed, 13 Sep 2023
Should You Buy Bruker Corporation (BRKR) Stock Wednesday? - InvestorsObserver

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 147 (M)
Shares Float 99 (M)
% Held by Insiders 32.3 (%)
% Held by Institutions 71.8 (%)
Shares Short 4,090 (K)
Shares Short P.Month 4,230 (K)

Stock Financials

EPS 2.16
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 8.39
Profit Margin (%) 11.7
Operating Margin (%) 17.8
Return on Assets (ttm) 8.3
Return on Equity (ttm) 28.5
Qtrly Rev. Growth 15.8
Gross Profit (p.s.) 8.92
Sales Per Share 18.45
EBITDA (p.s.) 3.95
Qtrly Earnings Growth 17.8
Operating Cash Flow 342 (M)
Levered Free Cash Flow 159 (M)

Stock Valuations

PE Ratio 28.84
PEG Ratio 1
Price to Book value 7.42
Price to Sales 3.37
Price to Cash Flow 26.78

Stock Dividends

Dividend 0.05
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.